Display options
Cite
Oh YK. Vasopressin and vasopressin receptor antagonists. Electrolyte Blood Press. 2008;6(1):51-5doi: 10.5049/EBP.2008.6.1.51.
Oh, Y. K. (2008). Vasopressin and vasopressin receptor antagonists. Electrolyte & blood pressure : E & BP, 6(1), 51-5. https://doi.org/10.5049/EBP.2008.6.1.51
Oh, Yun Kyu. "Vasopressin and vasopressin receptor antagonists." Electrolyte & blood pressure : E & BP vol. 6,1 (2008): 51-5. doi: https://doi.org/10.5049/EBP.2008.6.1.51
Oh YK. Vasopressin and vasopressin receptor antagonists. Electrolyte Blood Press. 2008 Jun;6(1):51-5. doi: 10.5049/EBP.2008.6.1.51. Epub 2008 Jun 30. PMID: 24459522; PMCID: PMC3894488.
Copy Download .nbib Format: NLM
Share it on

Electrolyte Blood Press. 2008 Jun;6(1):51-5. doi: 10.5049/EBP.2008.6.1.51. Epub 2008 Jun 30.

Vasopressin and vasopressin receptor antagonists.

Electrolyte & blood pressure : E & BP

Yun Kyu Oh

Affiliations

  1. Department of Internal Medicine, Seoul National University Boramae Hospital, Seoul National University College of Medicine, Seoul, Korea.

PMID: 24459522 PMCID: PMC3894488 DOI: 10.5049/EBP.2008.6.1.51

Abstract

Vasopressin, a neurohypophyseal peptide hormone, is the endogenous agonist at V1a, V1b, and V2 receptors. The most important physiological function of vasopressin is the maintenance of water homeostasis through interaction with V2 receptors in the kidney. Vasopressin binds to V2 receptor and increases the number of aquaporin-2 at the apical plasma membrane of collecting duct principal cells. That induces high water permeability across the membrane. Several non-peptide vasopressin receptor antagonists have been developed and are being studied primarily for treating conditions characterized by hyponatremia and fluid overload. Further studies are needed to determine how they are best used in these situations.

Keywords: aquaporin 2; hyponatremia; vasopressin receptor antagonist; vasopressins

References

  1. Am J Physiol. 1981 Oct;241(4):F432-42 - PubMed
  2. Physiol Rev. 2002 Jan;82(1):205-44 - PubMed
  3. Kidney Int. 2006 Jun;69(12):2124-30 - PubMed
  4. J Mol Endocrinol. 2002 Aug;29(1):1-9 - PubMed
  5. J Pharmacol Exp Ther. 2006 Feb;316(2):564-71 - PubMed
  6. Drugs. 2007;67(6):847-58 - PubMed
  7. JAMA. 2004 Apr 28;291(16):1963-71 - PubMed
  8. Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):96-103 - PubMed

Publication Types